A shopping feature published by USA TODAY says more women are adding collagen powder to their morning coffee after 40, choosing supplements that fit habits they already have rather than complicated multi-product routines. It runs as part of the outlet's Fall Reset, which USA TODAY describes as a curated shopping series covering beauty, wellness, personal care and other categories.

The product named is Alaya Naturals Multi Collagen Peptides. USA TODAY reports it combines five collagen types with MSM, glucosamine and chondroitin in a single scoop. Collagen peptides are short chains of amino acids derived from animal collagen, and the article describes MSM, glucosamine and chondroitin as ingredients commonly found in joint and connective tissue support supplements.

Five collagen types, one scoop

The pitch is convenience, and on its own terms it is a good one: powder that stirs into the coffee you were already making, no extra steps in a busy morning. USA TODAY puts it plainly, saying shoppers often prefer products that integrate into existing routines without requiring significant lifestyle changes. That is a lower bar than a five-step regimen, and it is most of why collagen powder keeps selling.

What the label is allowed to say

Per the article, the formula is positioned for women over 40 looking for a single daily supplement designed to support skin, hair, nail, joint, bone and connective tissue health. That sentence arrives with the article's own asterisk attached: the statements have not been evaluated by the Food and Drug Administration, and the product is not intended to diagnose, treat, cure or prevent any disease.

What NSF certification actually covers

An unflavored option is NSF Contents Certified, which USA TODAY presents as third-party ingredient verification for shoppers who prioritize ingredient transparency. Worth being clear about what that is and is not: it speaks to what is in the tub, not to what the tub does. The feature also lists the drawbacks, noting a multi-source collagen formula may not be appropriate for people with fish or poultry allergies, and that premium formulations may cost more than basic collagen peptide products.

What is missing

What is missing is any trial at all. No clinical trial, published study or outcome figure appears anywhere in the article, and no researcher or clinician is quoted. The comparisons it draws, such as a multi-collagen formula offering a broader collagen profile than single-source alternatives, are framed as points shoppers weigh rather than as tested results. For a formula built on five collagen types, that is a lot of specificity riding on no published data.

Bottom line

This is a shopping column doing what shopping columns do: documenting a consumer preference for simpler supplement routines and describing what one product contains. Its own disclaimer advises consulting a healthcare professional before starting any supplement regimen, and whether multi-collagen blends perform differently from single-source collagen peptides is not a question it addresses.